The flow cytometry-based assay measures the expression of the protein FcyR11a as a biomarker for cardiovascular risk.
Components of metabolic syndrome were associated with increased risks for all-cause and vascular dementia in a linear manner.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback